Diana Averbuch, Christina Orasch, Catherine Cordonnier, David M Livermore, Malgorzata Mikulska, Claudio Viscoli, Inge C Gyssens, Winfried V Kern, Galina Klyasova, Oscar Marchetti, Dan Engelhard, Murat Akova
Owing to increasing resistance and the limited arsenal of new antibiotics, especially against Gram-negative pathogens, carefully designed antibiotic regimens are obligatory for febrile neutropenic patients, along with effective infection control. The Expert Group of the 4(th) European Conference on Infections in Leukemia has developed guidelines for initial empirical therapy in febrile neutropenic patients, based on: i) the local resistance epidemiology; and ii) the patient's risk factors for resistant bacteria and for a complicated clinical course...
December 2013: Haematologica